Table 1.
Baseline characteristics of patients with and without sICH
| Variable | sICH | p value | |
|---|---|---|---|
| no, N = 409 (94.24%) | yes, N = 25 (5.76%) | ||
| Age, mean±SD | 68.45±14.22 | 70.88±12.49 | 0.403 |
| BMI, mean±SD | 24.93±4.07 | 25.07±3.20 | 0.863 |
| Gender | | | 0.184 |
| Male | 257 (62.84) | 19 (76.00) | |
| Female | 152 (37.16) | 6 (24.00) | |
| Initial SBP, mean±SD | 156.7±28.82 | 164.2±27.12 | 0.206 |
| Initial DBP, mean±SD | 92.05±18.50 | 94.72±22.55 | 0.490 |
| HTN | 342 (83.62) | 25 (100.0) | 0.020 |
| DM | 145 (35.45) | 9 (36.00) | 0.955 |
| CVA | 86 (21.03) | 7 (28.00) | 0.409 |
| Heart disease | 188 (45.97) | 16 (64.00) | 0.079 |
| Dyslipidemia | 308 (75.31) | 16 (64.00) | 0.207 |
| HF | 48 (11.74) | 2 (8.00) | 0.754 |
| Malignancy | 16 (3.91) | 2 (8.00) | 0.277 |
| Onset to tPA (min), mean±SD | 130.6±47.78 | 116.8±54.85 | 0.168 |
| tPA dose (mg/kg), mean±SD | 0.76±0.15 | 0.78±0.15 | 0.465 |
| Antiplatelet | 70 (17.11) | 5 (20.00) | 0.784 |
| Anticoagulation | 23 (5.62) | 2 (8.00) | 0.647 |
Values are presented as n (%) unless otherwise indicated. BMI, body mass index; DM, diabetes mellitus; HF, heart failure.